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Abstract
ZNF804a was identified by a genome-wide association study (GWAS) in which a single nucleotide polymorphism (SNP
rs1344706) in ZNF804a reached genome-wide statistical significance for association with a combined diagnosis of
schizophrenia (SZ) and bipolar disorder. Although the molecular function of ZNF804a is unknown, the amino acid sequence
is predicted to contain a C2H2-type zinc-finger domain and suggests ZNF804a plays a role in DNA binding and transcription.
Here, we confirm that ZNF804a directly contributes to transcriptional control by regulating the expression of several SZ
associated genes and directly interacts with chromatin proximal to the promoter regions of PRSS16 and COMT, the two
genes we find upregulated by ZNF804a. Using immunochemistry we establish that ZNF804a is localized to the nucleus of rat
neural progenitor cells in culture and in vivo. We demonstrate that expression of ZNF804a results in a significant increase in
transcript levels of PRSS16 and COMT, relative to GFP transfected controls, and a statistically significant decrease in
transcript levels of PDE4B and DRD2. Furthermore, we show using chromatin immunoprecipitation assays (ChIP) that both
epitope-tagged and endogenous ZNF804a directly interacts with the promoter regions of PRSS16 and COMT, suggesting a
direct upregulation of transcription by ZNF804a on the expression of these genes. These results are the first to confirm that
ZNF804a regulates transcription levels of four SZ associated genes, and binds to chromatin proximal to promoters of two SZ
genes. These results suggest a model where ZNF804a may modulate a transcriptional network of SZ associated genes.
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Introduction
Schizophrenia (SZ) is a heritable disorder having no single gene
or environmental factor that accounts for a majority of cases. An
emerging hypothesis to explain SZ etiology suggests that epistatic
interactions between multiple susceptibility genes all converge
onto a set of biological networks important for SZ pathology [1,2].
If SZ associated genes are closely connected to a common disease
pathway, then controlling the transcription of genes within this
network would be critical for proper biological function.
Therefore, we hypothesize that transcription factors associated
with SZ may be central to a transcriptional network that regulates
the expression of other SZ associated genes.
Genome-wide association studies (GWAS) are a powerful
method to identify single nucleotide polymorphisms (SNPs) that
are associated with a diagnosis. The first gene to reach genome-
wide significance for psychosis was ZNF804a when SNP
rs1344706 was significantly associated when schizophrenia and
bipolar disorder diagnoses are combined [3]. Several follow up
GWAS studies have replicated the association of rs1344706 with
SZ in different populations [4,5,6], and several other SNPs near
the ZNF804a locus have a significant association with SZ [7,8].
In many cases, SNPs significantly associated with a particular
diagnosis are located within intronic regions and therefore do not
alter the coding sequence of proteins, but rather may affect the
binding of transcription factors or alter the post-transcriptional
splicing of nearby genes. The rs1344706 SNP has been correlated
with increased ZNF804a transcript levels in adult tissue [4,9], and
the risk allele has a decreased affinity for nuclear proteins
compared to the common allele [10]. RNAi knockdown of
ZNF804a in an immortalized human neuroepithelium cell line
showed altered expression of genes involved in cell adhesion [11].
Although ZNF804a is a relatively strong candidate susceptibility
gene, the function of the protein and the molecular mechanism
responsible for enhancing risk for psychosis remains unknown.
Our overall aim was to determine the function of ZNF804a by
testing its ability to alter transcription of other SZ associated genes
and by performing chromatin immunoprecipitation assays (ChIP)
to determine if ZNF804a is specifically associated with promoter
regions of the regulated genes we identified. To this end, we
identify four SZ associated genes whose transcripts are regulated
by the expression level of ZNF804a in rat cortical progenitor cells.
In addition, we show that ZNF804a is associated with the
promoters of the two up-regulated genes in our study.
Results
SZ is a neurodevelopmental disorder with symptoms associated
with defects in cortical circuitry [12]. Therefore, we assayed
transcript levels in neural progenitors isolated from rat forebrain
at embryonic day 11 (E11). This population of progenitor cells
give rise to cortical and striatal neurons during embryonic
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population of progenitor cells express ZNF804a transcript as
measured by qRT-PCR (data not shown). To identify SZ
associated transcripts that are regulated downstream of
ZNF804a, we subcloned human ZNF804a into a plasmid with
a constitutive promoter (pCAG) creating pCAG-hZNF804a. We
also added an epitope-tag to ZNF804a so we could localize the
expressed protein and perform ChIP assays. 24 hours after
transfection of pCAG-hZNF804a immunocytochemistry with
anti-myc-tag antibodies revealed a predominantly nuclear
localization of ZNF804a (Figure 1A). We also observed nuclear
localization of endogenous ZNF804a protein in cortical progen-
itor cells in vivo using an antibody directed against ZNF804a
protein (Figure 1B). Furthermore, using subcellular fractionation,
we observed endogenous ZNF804a protein was absent in
cytoplasmic fraction but was clearly present in the nuclear
fraction (Figure 1C). These results suggest endogenous ZNF804a
is localized in the nucleus of neural progenitor cells both in vitro
and in vivo, and our recombinant ZNF804a expression construct
has a similar localization pattern to that observed for endogenous
ZNF804a protein.
We next asked if overexpression of ZNF804a in our neural
progenitor cell cultures could alter the transcript levels of other SZ
associated genes. We designed primers for the top 37 SZ
associated genes highlighted on the SZgene.org website (Table
S1; www.szgene.org/TopResults.asp; as of May 2011) [13] and
assayed mRNA levels by qRT-PCR. Neural progenitor cell
cultures where transfected for 24 hours with either pCAG-
ZNF804a or pCAG-GFP (transfection control) followed by
isolation of RNA. We observed a statistically significant increase
in transcript levels for two genes (Figure 2, red; COMT 3.1460.75
and PRSS16 4.6460.2; Bonferroni corrected p,0.05; n=5) and a
statistically significant decrease in transcript levels for two genes
(Figure 2, green; PDE4B 23.4360.23 and DRD2 23.1760.43;
Bonferroni corrected p,0.05; n=5) relative to GFP transfected
controls. These results indicate that ZNF804a expression can
modulate gene transcription, however with these results it is
unclear whether ZNF804a expression is directly and/or indirectly
regulating transcription.
To examine if ZNF804a expression may directly regulate
transcription, we performed ChIP to determine whether ZNF804a
directly interacts with genomic regions proximal to the promoters
of COMT, PRSS16, PDE4B, and DRD2, the four regulated genes
indentified in our qRT-PCR assays. Chromatin samples were
isolated from progenitor cultures transfected with pCAG-
ZNF804a. Proteins were cross-linked to DNA prior to isolation
and then sheered, chromatin was immunoprecipitated with an
anti-myc antibody, crosslinks reversed, and isolated DNA
subjected to qRT-PCR with a set of tiled primers spanning 2 kb
upstream of the annotated transcription start sites for PRSS16,
COMT, PDE4B, and DRD2 that included a GC-rich region
(Table S2; PRSS16, chr17:50145344-501473440, COMT
ch11:84579705-84581705; PDE4B, chr5:133600726-133602726
and DRD2, chr8: 50582050-50584050). To confirm our epitope-
tagged expression construct, we immunprecipitated protein from
transfected cells with anti-myc-tag antibody and detected it in
western blot with an anti-ZNF804a antibody (136 kDa; Figure 3a).
For our ChIP assays 1 mg of DNA was immunoprecipitated with
anti-myc-tag antibody or negative control IgG and expressed as
a percentage of input. Chromatin immunoprecipitated for
ZNF804a-myc was enriched in single distinct peaks within the
PRSS16 (Figure 3b; 26.260.4%, p,0.05; n=4) and COMT
(Figure 3c; 20.260.2%, p,0.05; n=4) 2 kB regions, but not
within 2 kB upstream of PDE4B or DRD2 genes (Figure 3d).
Furthermore, the genomic fragments that immunoprecipitated
with ZNF804a contained predicted zinc-finger interacting motifs
(COMT GGCGG; PRSS16 GGCG). These results indicate that
overexpressed ZNF804a directly interacts with the promoter
regions of PRSS16 and COMT and is consistent with ZNF804a
having a direct positive effect on the transcription of these two SZ
associated genes.
To rule out the possibility that overexpression of ZNF804a
results in artificial binding to DNA upstream for PRSS16 and
COMT, we determined whether endogenous ZNF804a protein
interacts with the same regions of PRSS16 and COMT. We
performed ChIP assays using anti-ZNF804a antibody in
untransfected neural progenitor cell cultures. Similar to ChIP
results for the overexpressed ZNF804a protein ChIP for
endogenous ZNF804a protein enriched DNA sequence within
the PRSS16 (Figure 4a; 4.960.03%, p,0.05; n=5) and COMT
(Figure 4b; 4.260.06%, p,0.05; n=5) promoter regions.
Moreover, the enriched peaks were in the same locations for
Figure 1. Recombinant and endogenous ZNF804a is localized
to the nucleus of neural progenitor cells. A) pCAG-ZNF804A was
transfected into rat neural progenitor cells for twenty-four hours and
processed for immunocytochemistry with antibodies against an myc-
tag fused to ZNF804a. Expression of ZNF804a co-localizes with the
nuclear counter stain DAPI (Scale bar=10 mm). B) Immunohistochem-
istry using anti-ZNF804a antibodies showing endogenous ZNF804a
protein (left panel) co-localizes (right panel) with the nuclear counter
stain TOPRO (middle panel) in E11 neural progenitor cells within the
ventricle zone. C) Endogenous ZNF804a protein is devoid of the
cytoplasmic fraction and observed in the nuclear fraction. As a control
to demonstrate proper cellular fractionation, Nestin, a cytoplasmic
marker of neural progenitor cells, is observed in the cytoplasmic
fraction. Likewise, Histone H3, a chromatin marker, is observed in the
nuclear fraction.
doi:10.1371/journal.pone.0032404.g001
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are consistent with ZNF804a contributing directly to the
regulation of transcription.
Discussion
This study identifies several putative SZ-associated genes that
are transcriptionally regulated by ZNF804a overexpression. We
show that endogenous and recombinant ZNF804a localize to the
nucleus of neural progenitor cells in vitro and in vivo. In addition,
we show a direct interaction of endogenous and recombinant
protein interacting with regions immediately upstream of the start
sites of PRSS16 and COMT, two genes we observed that were
upregulated by ZNF804a expression.
Three genes we observed to be regulated by ZNF804a
expression are directly involved in dopaminergic transmission
and cAMP signaling, two pathways thought to underlie many of
the symptoms of psychosis. Specifically, COMT is an enzyme that
degrades catecholamines in the synaptic cleft and SNPs within the
coding sequence of this gene are associated with cognitive deficits
[14]. DRD2 encodes the D2 subtype of the dopamine receptor
and activation of this receptor by dopamine inhibits adenylate
cyclase activity. PDE4B encodes the cAMP-specific phosphodies-
terase 4B, an enzyme responsible for the breakdown of cAMP. We
find this grouping of regulated genes to be very interesting because
they are closely associated with a common signaling pathway.
These genes are clearly important for adult brain function, but
determining how altered prenatal expression of these genes will
effect neurodevelopment will need further investigation.
Direct binding of ZNF804a to its promoter region also positively
regulated the expression level of PRSS16. PRSS16 encodes a
serine protease located on chromosome 6 near the major
histocompatability complex (MHC) class I region of the genome.
A SNP in this region of the genome (6p22.1) reached genome-wide
association for SZ [15,16]. Expression of this gene is most
abundantly observed in the thymus, however expression is found
in other tissues including brain [17]. PRSS16 is an interesting gene
because of its role in immune function. Immune function is
thought to be important in the etiology of SZ as prenatal influenza
increases risk of SZ [18]. However, the function of PRSS16 during
brain development is unknown.
Given the intronic location of SNP rs1233706 within the
ZNF804a gene, altered expression or splice variation may confer
SZ susceptibility. The alleles of SNP rs1344706 are shown to
differentially bind nuclear proteins and suggest a molecular
mechanism for altering ZNF804a expression [10]. In addition,
the rs1344706 risk allele is associated with increased expression in
the dorsolateral prefrontal cortex [4]. However, in lymphoblastoid
cells, increased expression generally associates with SNP
rs1344706, however rs1344706 does not appear to be the only
cis-acting eQTL responsible for expression [9]. It will be
important in future studies to better characterize how this SNP
alters expression in fetal and adult brain to more precisely match
appropriate expression levels in cell and animal models.
Beyond developmental expression, understanding the function and
determining the genes that are regulated by ZNF804a either directly
through promoter/enhancer occupancy or indirectly through
downstream molecular pathways is relevant to our understanding
o ft h ef u n c t i o no ft h i sg e n ea n dh o wi tm a ya s s o c i a t ew i t hS Z .
Regardless of the expression pattern observed in SZ, our data and
others suggest that transcription downstream of ZNF804a is sensitive
to the expression level of ZNF804a [11]. Using a whole-genome
microarray approach, Hill et al. [11] showed RNAi knockdown of
ZNF804a in human neural progenitor cell line resulted in altered
expression of 151 unique genes, however this study could not
ascertain if knockdown of ZNF804a produced a direct or indirect
effect on gene expression. Our ChIP results expand our understand-
ing of ZNF804a function by providing evidence of ZNF804a directly
regulating transcription through promoter/enhancer occupancy. It
Figure 2. ZNF804a regulates the transcription of several Schizophrenia- associated genes. A) Quantitative RT-PCR was performed on 37
SZ associated gene transcripts following ZNF804A transfection. PRSS16 and COMT (red) showed robust upregulation of transcription twenty-four
hours after transfection (Bonferroni corrected p,0.05; n=5). Conversely, PDE4B and DRD2 (green) transcript levels were downregulated following
ZNF804a transfection (Bonferroni corrected p,0.05; n=5).
doi:10.1371/journal.pone.0032404.g002
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Chromatin was immunoprecipitated with antibody directed against the myc-tag or IgG as control and then probed with anti-ZNF804a antibody.
Recombinant ZNF804a was correctly identified by anti-ZNF804a antibody. B–C) Tiling qRT-PCR of the promoter sequences of PRSS16 and COMT
following ChIP against the myc-tag reveals enrichment for ZNF804A. Enrichment of ZNF804A on the PRSS16 promoter appears 1.5 Kb 59 upstream of
the transcription start sites (TSS) while enrichment on the COMT promoter appears 1 Kb 59 upstream of the TSS D) Tiling qRT-PCR of the promoter
sequences of DRD2 and PDE4B following ChiP did not result in enrichment of ZNF804a (all figures *p,0.05, Students t-test, Error bars indicate 6 SEM).
doi:10.1371/journal.pone.0032404.g003
Figure 4. Endogenous ZNF804a binds to the DNA regions directly upstream of the transcription start site of PRSS16 and COMT. A)
Tiling qRT-PCR of the promoter sequences of PRSS16 and COMT following ChIP using anti-ZNF804a reveals enrichment for ZNF804A. Enrichment of
ZNF804A on the PRSS16 promoter appears 1.5 Kb 59 upstream of the transcription start sites (TSS) while enrichment on the COMT promoter appears
1K b5 9 upstream of the TSS.
doi:10.1371/journal.pone.0032404.g004
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genome-wide ChIP sequencing approach. Collectively, these results
strongly suggest ZNF804a expression level is a candidate mechanism
for conferring risk.
Materials and Methods
Ethics Statement
All studies were conducted in accordance with protocols that
were approved by the University of Connecticut Institutional
Animal Care and Use Committee (IACUC; Assurance No. A09-
025, 2/2011). The facilities at the University of Connecticut are
accredited by the Association for the Assessment and Accredita-
tion of Laboratory Animal Care (AAALAC).
Nuclear isolation
Nuclei were extracted from confluent neural progenitors
(,90%) using the CelLytic Nuclear extraction Kit from Sigma
(NXTRACT). Briefly, cells were swelled with a hypotonic buffer.
They were then disrupted and cytoplasmic extract was removed.
The nuclear extract was isolated from the remaining lysate with a
high salt buffer.
Western Blot Analysis
Chromatin recovered by myc-tag or IgG immunoprecipitation
from rat neural progenitors was resolved by 15% sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE), transferred
to nitrocellulose, probed with a ZNF804a antibody (Santa Cruz
Biotechnology), and visualized on an Odyssey Infrared Imager.
Immunohistochemistry
Brains were dissected from E13 rat embryos. Paraffin embedded
brains were cut on a cryostat. Cortical sections were taken and
immunohistochemistry was performed. Sections were stained
using antibodies against ZNF804A (1:500; Santa Cruz Biotech-
nology) with a nuclear counter stain TO-PRO (Invitrogen, T-
3605). Anti-rabbit 488 secondary antibody (1:400, Molecular
Probes) was used for fluorescent imaging. Images were taken with
a Leica TCS SP2 confocal microscope.
Quantitative PCR
RNA (1 mg) was reverse-transcribed into cDNA using oligo-dT
primers and reverse-transcriptase. RNA was then hydrolyzed, and
re-suspended in nuclease-free water. Gene-specific primers were
designed using Primer 3 software (http://frodo.wi.mit.edu/
primer3/) and tested for efficiency and specificity by serial
dilutions and melt curve analysis. Sybr Green mix (ABI) was used
to amplify cDNA. Primer sequences are in Table S1.
Chromatin Immunoprecipitation
Chromatin immunoprecipitations were performed as described
with several modifications (below). Briefly, chromatin isolated from
rat neural progenitors (10
6) was sonicated into 200 to 500 base pair
(bp) fragments. Resulting samples were immunoprecipitated with
5 mg myc-tag antibody (Abcam, ab9132), 10 mg ZNF804a
antibody (Santa Cruz Biotechnology), or 5 mg normal rabbit
immunoglobulin G (IgG) (Sigma I8140). Immunoprecipitated
DNA was probed by qRT-PCR using promoter specific tiling
primers across the promoters of PRSS16, COMT, DRD2 and
PDE4B. Primer sequences are in Table S2.
Supporting Information
Table S1 Table of all the gene names and primers used in qRT-
PCR experiments. Threshold values for qPCR in each condition,
wild type (WT) and wild type transfected with ZNF804A (ZNF)
followed by the first delta Ct after Gapdh normalization. Fold
Regulation was calculated and a standard error of the mean for
each condition.
(TIF)
Table S2 Tiling primers used in ChIP experiments. Table of
tiling primers of promoters for qRT-PCR combined with
chromatin immunoprecipitation. All primers are ordered by
distance from the transcription start site (TSS) of each gene
starting with 1 (2 Kb away) to 8 (on the TSS).
(TIF)
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